Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs
Open Access
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (34) , 35822-35828
- https://doi.org/10.1074/jbc.m405761200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genomeNature Structural & Molecular Biology, 2004
- The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus InfectivityJournal of Virology, 2003
- HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradationNature Medicine, 2003
- DNA Deamination Mediates Innate Immunity to Retroviral InfectionCell, 2003
- The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNANature, 2003
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Hypermutation of HIV-1 DNA in the Absence of the Vif ProteinScience, 2003
- Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family businessTrends in Genetics, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.Proceedings of the National Academy of Sciences, 1990